OTC Pharmaceuticals - D-A-CH

  • D-A-CH
  • The OTC Pharmaceuticals market in D-A-CH is projected to generate revenue of US$13.31bn in 2024.
  • It is expected to experience an annual growth rate of 2.91% (CAGR 2024-2029).
  • Among the various markets, Other OTC Pharmaceuticals holds the largest market share with a volume of US$5.32bn in 2024.
  • In comparison to other countries, the in the United States leads in revenue generation with US$41,240.00m in 2024.
  • When considering the population, per person revenues amount to US$131.60 in 2024.
  • Furthermore, online sales are estimated to contribute 15.40% of the total revenue in the OTC Pharmaceuticals market by 2024.
  • Germany's OTC Pharmaceuticals market is driven by a preference for natural remedies and a strong pharmacy network.

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in D-A-CH, which includes Germany, Austria, and Switzerland, is experiencing steady growth due to several factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the development of this market.Customer preferences in the D-A-CH region play a significant role in the growth of the OTC Pharmaceuticals market. Consumers in these countries have a strong preference for self-medication and are increasingly turning to over-the-counter products for minor ailments. This preference is driven by factors such as convenience, cost-effectiveness, and a desire for immediate relief. Additionally, the high level of health literacy in the region encourages consumers to take an active role in managing their health, further driving the demand for OTC Pharmaceuticals.Trends in the market also contribute to the growth of the OTC Pharmaceuticals market in D-A-CH. One notable trend is the increasing focus on preventive healthcare. Consumers are becoming more proactive in maintaining their well-being and are seeking OTC products that can help prevent illness or manage chronic conditions. This trend is driving the demand for vitamins, supplements, and preventive medications, which are readily available in the OTC Pharmaceuticals market.Another trend in the market is the growing popularity of natural and herbal remedies. Consumers in D-A-CH have a strong preference for natural products and are increasingly turning to herbal remedies for various health concerns. This trend is reflected in the wide range of herbal and homeopathic OTC products available in the market. Manufacturers are capitalizing on this trend by introducing new natural and herbal OTC products to meet consumer demand.Local special circumstances also contribute to the development of the OTC Pharmaceuticals market in D-A-CH. One such circumstance is the well-established healthcare system in these countries. The availability of high-quality healthcare services, including pharmacies, contributes to the accessibility and popularity of OTC Pharmaceuticals. Additionally, the strong regulatory framework ensures the safety and efficacy of these products, further enhancing consumer trust and confidence.Underlying macroeconomic factors also play a role in the growth of the OTC Pharmaceuticals market in D-A-CH. The stable economies of Germany, Austria, and Switzerland provide consumers with the purchasing power to afford OTC products. Additionally, the aging population in these countries contributes to the demand for OTC Pharmaceuticals, as older adults often require medications for chronic conditions that can be managed with OTC products.In conclusion, the OTC Pharmaceuticals market in D-A-CH is developing due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The strong preference for self-medication, the focus on preventive healthcare, the popularity of natural and herbal remedies, the well-established healthcare system, and the stable economies all contribute to the growth of this market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)